NCT02074410View on ClinicalTrials.gov

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 15, 2014

Study Completion Date

October 15, 2014

Conditions

Huntington's Disease

Interventions

DRUG

OMS643762

DRUG

Placebo

Trial Locations (9)

10032

New York

21287

Baltimore

32607

Gainesville

33612

Tampa

38163

Memphis

77030

Houston

80113

Englewood

92037

San Diego

98034

Kirkland

Sponsors

Lead Sponsor

Omeros Corporation

All Listed Sponsors

lead

Omeros Corporation

INDUSTRY